Addex Therapeutics (ADXN) Liabilities from Discontinued Operations: 2023-2025
Historic Liabilities from Discontinued Operations for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to -$4.1 million.
- Addex Therapeutics' Liabilities from Discontinued Operations fell 71.02% to -$4.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$4.1 million, marking a year-over-year decrease of 71.02%. This contributed to the annual value of $13.6 million for FY2024, which is 251.63% up from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Liabilities from Discontinued Operations is -$4.1 million, which was down 153.04% from -$1.6 million recorded in Q1 2025.
- Addex Therapeutics' 5-year Liabilities from Discontinued Operations high stood at $13.7 million for Q4 2024, and its period low was -$9.1 million during Q4 2023.
- Moreover, its 3-year median value for Expense - Real Estate was $128,480 (2024), whereas its average is $588.0 million.
- Per our database at Business Quant, Addex Therapeutics' Expense - Real Estate slumped by 159.27% in 2024 and then climbed by 5.27% in 2025.
- Over the past 3 years, Addex Therapeutics' Liabilities from Discontinued Operations (Quarterly) stood at -$9.1 million in 2023, then soared by 250.39% to $13.7 million in 2024, then crashed by 71.02% to -$4.1 million in 2025.
- Its Liabilities from Discontinued Operations stands at -$4.1 million for Q2 2025, versus -$1.6 million for Q1 2025 and $13.7 million for Q4 2024.